These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 32884031)

  • 21. Postprandial changes in glucose oxidation and insulin sensitivity in metabolic syndrome: Influence of fibroblast growth factor 21 and vitamin D status.
    Pathak K; Soares MJ; Zhao Y; James AP; Sherriff JL; Newsholme P
    Nutrition; 2017 May; 37():37-42. PubMed ID: 28359360
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The association of serum FGF23 and non-alcoholic fatty liver disease is independent of vitamin D in type 2 diabetes patients.
    He X; Shen Y; Ma X; Ying L; Peng J; Pan X; Bao Y; Zhou J
    Clin Exp Pharmacol Physiol; 2018 Jul; 45(7):668-674. PubMed ID: 29574933
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of serum fibroblast growth factor 21 with kidney function in a population-based Chinese cohort.
    Zhang R; Li Y; Zhou X; Zhang F; Li M; Zhang S; Zhang X; Wen X; Ji L
    Medicine (Baltimore); 2021 Dec; 100(50):e28238. PubMed ID: 34918690
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of vitamin D replacement therapy in serum FGF23 concentration in children with myelomeningocele compared with healthy children - a preliminary study.
    Bagińska J; Liszewska A; Korzeniecka-Kozerska A
    J Pediatr Endocrinol Metab; 2019 Nov; 32(11):1259-1264. PubMed ID: 31465293
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genome-wide Association Study for Vitamin D Levels Reveals 69 Independent Loci.
    Manousaki D; Mitchell R; Dudding T; Haworth S; Harroud A; Forgetta V; Shah RL; Luan J; Langenberg C; Timpson NJ; Richards JB
    Am J Hum Genet; 2020 Mar; 106(3):327-337. PubMed ID: 32059762
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dynamic Changes in Circulating Endocrine FGF19 Subfamily and Fetuin-A in Response to Intralipid and Insulin Infusions in Healthy and PCOS Women.
    Ramanjaneya M; Bensila M; Bettahi I; Jerobin J; Samra TA; Aye MM; Alkasem M; Siveen KS; Sathyapalan T; Skarulis M; Atkin SL; Abou-Samra AB
    Front Endocrinol (Lausanne); 2020; 11():568500. PubMed ID: 33101202
    [No Abstract]   [Full Text] [Related]  

  • 27. Low serum iron is associated with high serum intact FGF23 in elderly men: The Swedish MrOS study.
    Lewerin C; Ljunggren Ö; Nilsson-Ehle H; Karlsson MK; Herlitz H; Lorentzon M; Ohlsson C; Mellström D
    Bone; 2017 May; 98():1-8. PubMed ID: 28212898
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genome-wide associations and detection of potential candidate genes for direct genetic and maternal genetic effects influencing dairy cattle body weight at different ages.
    Yin T; König S
    Genet Sel Evol; 2019 Feb; 51(1):4. PubMed ID: 30727969
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Candidate Gene and Genome-Wide Association Studies for Circulating Leptin Levels Reveal Population and Sex-Specific Associations in High Cardiovascular Risk Mediterranean Subjects.
    Ortega-Azorín C; Coltell O; Asensio EM; Sorlí JV; González JI; Portolés O; Saiz C; Estruch R; Ramírez-Sabio JB; Pérez-Fidalgo A; Ordovas JM; Corella D
    Nutrients; 2019 Nov; 11(11):. PubMed ID: 31766143
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship of fibroblast growth factor 21 with kidney function and albuminuria: multi-ethnic study of atherosclerosis.
    Anuwatmatee S; Allison MA; Shlipak MG; McClelland RL; Kramer H; Tang S; Hou L; Rye KA; Ong KL
    Nephrol Dial Transplant; 2019 Jun; 34(6):1009-1016. PubMed ID: 29771383
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population.
    Mirza MA; Larsson A; Melhus H; Lind L; Larsson TE
    Atherosclerosis; 2009 Dec; 207(2):546-51. PubMed ID: 19524924
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum fibroblast growth factor 23 and mineral metabolism in patients with euthyroid Graves' diseases: a case-control study.
    Lin CH; Chang CK; Shih CW; Li HY; Chen KY; Yang WS; Tsai KS; Wang CY; Shih SR
    Osteoporos Int; 2019 Nov; 30(11):2289-2297. PubMed ID: 31384956
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum and urine FGF23 and IGFBP-7 for the prediction of acute kidney injury in critically ill children.
    Bai Z; Fang F; Xu Z; Lu C; Wang X; Chen J; Pan J; Wang J; Li Y
    BMC Pediatr; 2018 Jun; 18(1):192. PubMed ID: 29907141
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Daily physical activity, fasting glucose, uric acid, and body mass index are independent factors associated with serum fibroblast growth factor 21 levels.
    Cuevas-Ramos D; Almeda-Valdes P; Gómez-Pérez FJ; Meza-Arana CE; Cruz-Bautista I; Arellano-Campos O; Navarrete-López M; Aguilar-Salinas CA
    Eur J Endocrinol; 2010 Sep; 163(3):469-77. PubMed ID: 20566587
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fibroblast growth factor 23 is associated with the presence of coronary artery disease and the number of stenotic vessels.
    Hu X; Ma X; Pan X; Hao Y; Luo Y; Lu Z; Bao Y; Jia W
    Clin Exp Pharmacol Physiol; 2015 Nov; 42(11):1152-7. PubMed ID: 26217893
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patterns of Circulating Fibroblast Growth Factor 21 in Subjects with and without Type 2 Diabetes.
    Lu J; Yu H; Mo Y; Ma X; Hao Y; Lu W; Li H; Bao Y; Zhou J; Jia W
    PLoS One; 2015; 10(11):e0142207. PubMed ID: 26540514
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between fibroblast growth factor 21 and bone mineral density in adults.
    Hao RH; Gao JL; Li M; Huang W; Zhu DL; Thynn HN; Dong SS; Guo Y
    Endocrine; 2018 Feb; 59(2):296-303. PubMed ID: 29299795
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Iron deficiency, elevated erythropoietin, fibroblast growth factor 23, and mortality in the general population of the Netherlands: A cohort study.
    Eisenga MF; De Jong MA; Van der Meer P; Leaf DE; Huls G; Nolte IM; Gaillard CAJM; Bakker SJL; De Borst MH
    PLoS Med; 2019 Jun; 16(6):e1002818. PubMed ID: 31170159
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral vitamin D
    Charoenngam N; Rujirachun P; Holick MF; Ungprasert P
    Osteoporos Int; 2019 Nov; 30(11):2183-2193. PubMed ID: 31372708
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of Cholecalciferol therapy on serum FGF
    Kamelian T; Saki F; Jeddi M; Dabbaghmanesh MH; Omrani GHR
    J Endocrinol Invest; 2018 Mar; 41(3):299-306. PubMed ID: 28795342
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.